2012
DOI: 10.1039/c2nj20873c
|View full text |Cite
|
Sign up to set email alerts
|

Glycodendrimers as functional antigens and antitumor vaccines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
59
0
1

Year Published

2012
2012
2017
2017

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 88 publications
(60 citation statements)
references
References 88 publications
0
59
0
1
Order By: Relevance
“…Potentially, these nanoparticles can be successfully used not only as vectors of targeted delivery of drugs to cancer cells, but also as stimulants to augment the anti-tumor attack of the innate immune system. This mild adjuvant-like effect of glycodendrimers was previously mentioned in the study on their use in facilitating anti-tumor vaccine application, but no molecular mechanism was proposed (40). …”
Section: Discussionmentioning
confidence: 88%
“…Potentially, these nanoparticles can be successfully used not only as vectors of targeted delivery of drugs to cancer cells, but also as stimulants to augment the anti-tumor attack of the innate immune system. This mild adjuvant-like effect of glycodendrimers was previously mentioned in the study on their use in facilitating anti-tumor vaccine application, but no molecular mechanism was proposed (40). …”
Section: Discussionmentioning
confidence: 88%
“…Following the same approach, BSA-conjugated vaccines (4) have been prepared with various divalent combinations of sialylated and unsialylated antigens (Fig. 14.4).…”
Section: Protein Carriersmentioning
confidence: 99%
“…27 Screening of the library by adding concanavalin A (Con A), an aMan specific lectin, to the equilibrating mixture of library components did not evidenced significant differences in the binding affinity within the heterodimer series (Scheme 3). A second family of dynamic carbohydrate libraries was generated from a pool of carbohydrate aldehydes (16)(17)(18)(19)(20)(21) and di-or tritopic hydrazide components (A-H) through reversible acylhydrazone exchange (Scheme 4). 28 The library members can thus incorporate up to three different glycotopes (e.g.…”
Section: (A) ''Shuffled'' Heteroglycoconjugatesmentioning
confidence: 99%
“…[4][5][6][7][8] Synthetic polyconjugates with welldefined structures have contributed to unravel the mechanisms at work, [9][10][11][12] leading eventually to useful tools for biotechnological 13,14 or therapeutic purposes. 15 Typically, these systems incorporate several copies of identical sugar motifs attached to an appropriate scaffold (molecular, dendritic, polymeric) 10,11,[16][17][18] or self-assembled in supramolecular constructs (nanoparticles, vesicles, microarrays). 11,19 It has been amply demonstrated that ligand multivalency increases protein-binding avidities dramatically.…”
Section: Introductionmentioning
confidence: 99%